Cargando…

IFISTRATEGY: Spanish National Survey of Invasive Fungal Infection in Hemato-Oncologic Patients

Recent advances in the treatment of hematologic malignancies have improved the overall survival rate, but the number of patients at risk of developing an invasive fungal infection (IFI) has increased. Invasive infections caused by non-Candida albicans species, non-Aspergillus molds, and azole-resist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vallejo, Carlos, Jarque, Isidro, Fortun, Jesus, Casado, Araceli, Peman, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303963/ https://www.ncbi.nlm.nih.gov/pubmed/37367564 http://dx.doi.org/10.3390/jof9060628

Ejemplares similares

P1595: IFISTRATEGY: A SPANISH NATIONAL SURVEY ON STRATEGIES FOR MANAGEMENT OF INVASIVE FUNGAL INFECTION AND GUIDELINES APPLICATION IN HIGH RISK ONCO-HEMATOLOGICAL PATIENTS
por: Vallejo, C., et al.
Publicado: (2022)

Strategies for the management of invasive fungal infections due to filamentous fungi in high-risk hemato-oncological patients
por: Vallejo, Carlos, et al.
Publicado: (2019)

Voriconazole in the management of nosocomial invasive fungal infections
por: Pemán, Javier, et al.
Publicado: (2006)

Stem Cells in Hemato-Oncology
por: Damodar, S
Publicado: (2006)

Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?
por: Zaragoza, Rafael, et al.
Publicado: (2008)

Parasitic Infections in Hematopoietic Stem Cell Transplantation
por: Jarque, Isidro, et al.
Publicado: (2016)

PRES in the course of hemato-oncological treatment in children
por: Musioł, Katarzyna, et al.
Publicado: (2017)

Cessation of Ciprofloxacin Prophylaxis in Hemato-Oncology Patients
por: Caldwell, Louise, et al.
Publicado: (2022)

Palestinian Children in the Hemato-Oncology Ward of an Israeli Hospital
por: Nehari, Miri, et al.
Publicado: (2008)

Monitoring of the Environment at the Transplant Unit—Hemato-Oncology Clinic
por: Matoušková, Ivanka, et al.
Publicado: (2014)

Hemato-oncology Tourism in Israel: A Retrospective Review
por: Hod, Keren, et al.
Publicado: (2020)

COVID-19 in Omani Children with Hemato-Oncology Diseases
por: Al Yazidi, Laila S, et al.
Publicado: (2020)

Analysis of Vancomycin-Resistant Enterococci in Hemato-Oncological Patients
por: Hricová, Kristýna, et al.
Publicado: (2020)

Utility of Galactomannan Screening for Early Detection of Invasive Aspergillosis in High-Risk Hemato-Oncology Patients
por: Sabbah, Rozan, et al.
Publicado: (2023)

Catheter-related bloodstream infections in hemato-oncology paediatric patients
por: Giamberardino, HIG, et al.
Publicado: (2015)

Platelet Septic Transfusion Reactions in Patients With Hemato-Oncological Diseases
por: Razjou, Farhad, et al.
Publicado: (2017)

Pediatric Hemato-Oncology Care Amid the COVID-19 Pandemic
por: Sahi, Puneet Kaur, et al.
Publicado: (2021)

Remdesivir Reduces Mortality in Hemato-Oncology Patients with COVID-19
por: Aksak-Wąs, Bogusz Jan, et al.
Publicado: (2022)

Roadbook for the implementation of next-generation sequencing in clinical practice in oncology and hemato-oncology in Belgium
por: Van Valckenborgh, Els, et al.
Publicado: (2018)

Supportive Care in Hemato-Oncology: A Review in Light of the Latest Guidelines
por: Gündüz, Eren, et al.
Publicado: (2012)

Risk of Infectious Complications in Hemato-Oncological Patients Treated with Kinase Inhibitors
por: Reinwald, Mark, et al.
Publicado: (2016)

Prevention of HBV Reactivation in Hemato-Oncologic Setting during COVID-19
por: Sagnelli, Caterina, et al.
Publicado: (2022)

Evaluation of Asymptomatic Covid Infection in Children with Pediatric Hemato-Oncologic Disease
por: Bahadir, Aysenur, et al.
Publicado: (2022)

NGS for (Hemato-) Oncology in Belgium: Evaluation of Laboratory Performance and Feasibility of a National External Quality Assessment Program
por: Delcourt, Thomas, et al.
Publicado: (2020)

Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain
por: Grau, Santiago, et al.
Publicado: (2012)

Hemato- Oncology Care in COVID-19 Pandemic: Crisis within a Crisis
por: Seth, Tulika, et al.
Publicado: (2020)

The Profile of Microorganisms Responsible for Port-Related Bacteremia in Pediatric Hemato-Oncological Patients
por: Gowin, Ewelina, et al.
Publicado: (2020)

Hemato-Oncological Diseases as Risk Factor for Recurrence or Metastasis of Pleomorphic Dermal Sarcoma
por: Helbig, Doris
Publicado: (2022)

Impact of Male Hypogonadism on Bone Mineral Density in Childhood Hemato-Oncologic Disease
por: Kim, Sungeun, et al.
Publicado: (2021)

Hemato-oncología pediátrica
Publicado: (2006)

Audit of In-Hospital Mortality from a Medical Oncology and Hemato-Oncology Center with the Emphasis on Best Supportive Care
por: Sundriyal, Deepak, et al.
Publicado: (2022)

Is hyperlactatemia a useful screening marker of severe sepsis in hemato-oncologic malignant patients?
por: Park, S, et al.
Publicado: (2015)

Feasibility and suitability of a graded exercise test in patients with aggressive hemato-oncological disease
por: Großek, Anja, et al.
Publicado: (2021)

Screening of SARS-CoV-2 in 299 Hospitalized Children with Hemato-oncological Diseases: A Multicenter Survey in Hubei, China
por: Wang, Song-mi, et al.
Publicado: (2020)

Diagnostic and therapeutic approach to fungal pneumonia in the critically ill patient
por: Fortún, Jesús
Publicado: (2022)

Association of systolic blood pressure drop with intravenous administration of itraconazole in children with hemato-oncologic disease
por: Lee, Hyeong Jin, et al.
Publicado: (2015)

Expected individual benefit of prophylactic platelet transfusions in hemato‐oncology patients based on bleeding risks
por: Cornelissen, Loes L., et al.
Publicado: (2021)

Management of Treatment-Related Infectious Complications in High-Risk Hemato-Oncological Patients via Telemedicine
por: Hradská, Katarína, et al.
Publicado: (2022)

The Impact of Clinical Pharmacy Services in a Tertiary Care Center Specialized in Pediatric Hemato-Oncology
por: Gradwohl, Christina, et al.
Publicado: (2022)

Altered Fc glycosylation of anti‐HLA alloantibodies in hemato‐oncological patients receiving platelet transfusions
por: van Osch, Thijs L. J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_idhc64n1441frsmi75cgib1hgu